FDA Inspection
Mission Pharmacal CompanyMission Pharmacal Company – FDA Inspection, May 4, 2017
Record Details
This FDA Inspection record concerns Mission Pharmacal Company, with an inspection on May 4, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c221bfd4-0ff6-4b79-b9cb-04276bae4388
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1019109
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Mission Pharmacal Company
8| Date | Classification | Office | Project area |
|---|---|---|---|
| June 27, 2023 | NAI | Center for Food Safety and Applied Nutrition | Food Composition, Standards, Labeling and Econ |
| September 22, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 4, 2019 | VAI | Dallas District Office | New Drug Evaluation |
| September 20, 2018 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| February 7, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Mission Pharmacal Company
- FDA Inspection 1219105 - 2023-06-27
- FDA Inspection 1180935 - 2022-09-22
- FDA Inspection 1085124 - 2019-04-04
- FDA Inspection 1067651 - 2018-09-20
- FDA Inspection 866629 - 2014-02-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.